Northwire Canada EditionFriday, July 17, 2026
Sign inSubscribe
Northwire
⌕
ZNX 0.080 +0.0% TSK 1.06 +0.9% SFR 0.370 +68.2% OMM 0.050 +0.0% EMO 0.340 −1.4% GGA 5.37 +1.3% MDM 0.060 +0.0% WGX 4.33 −2.3% FL 0.410 +0.0% SSRM 36.32 −0.1% CD 0.245 +6.5% GEN 0.065 −7.1% ALS 56.22 −2.2% LIFT 3.26 +3.5% NTR 94.21 −0.1% ICON 0.045 +0.0% ZNX 0.080 +0.0% TSK 1.06 +0.9% SFR 0.370 +68.2% OMM 0.050 +0.0% EMO 0.340 −1.4% GGA 5.37 +1.3% MDM 0.060 +0.0% WGX 4.33 −2.3% FL 0.410 +0.0% SSRM 36.32 −0.1% CD 0.245 +6.5% GEN 0.065 −7.1% ALS 56.22 −2.2% LIFT 3.26 +3.5% NTR 94.21 −0.1% ICON 0.045 +0.0%

Healthcare

Page 104
  1. Nov 12, 2025 · 20:07 · PCRX

    Pharmacorp Rx closes $23-million bought deal offering

    Pharmacorp Rx closes $23-million bought deal offering

    01
  2. Nov 12, 2025 · 19:40 · CYTO

    Cytophage Announces Closing of First Tranche of Non-Brokered Private Placement

    Cytophage Announces Closing of First Tranche of Non-Brokered Private Placement

    02
  3. Nov 12, 2025 · 18:52 · PRN

    Profound signs Australia, NZ distribution deal

    Profound signs Australia, NZ distribution deal

    03
  4. Nov 12, 2025 · 18:07 · MDP

    Medexus Announces Fiscal Q2 2026 Results, Driven by Strong Year-To-Date Product-Level Performance of GRAFAPEX (treosulfan) for Injection

    Medexus Announces Fiscal Q2 2026 Results, Driven by Strong Year-To-Date Product-Level Performance of GRAFAPEX (treosulfan) for Injection

    04
  5. Nov 12, 2025 · 16:59 · PINK

    Perimeter Medical Imaging AI Announces Strong Third Quarter 2025 Financial Results

    Perimeter Medical Imaging AI Announces Strong Third Quarter 2025 Financial Results

    05
  6. Nov 12, 2025 · 16:29 · MBX

    Microbix aids Sekisui Covid/flu test rollout in U.S.

    Microbix aids Sekisui Covid/flu test rollout in U.S.

    06
  7. Nov 12, 2025 · 16:05 · GLAS

    Glass House Brands Reports Third Quarter 2025 Financial Results

    Glass House Brands Reports Third Quarter 2025 Financial Results

    07
  8. Nov 12, 2025 · 16:02 · NRX

    NurExone Secures over C$3.18 Million Through Accelerated Warrant Exercises

    NurExone Secures over C$3.18 Million Through Accelerated Warrant Exercises

    08
  9. Nov 12, 2025 · 09:28 · PCRX

    PharmaCorp Announces Closing of C$23 Million Bought Deal Public Offering

    PharmaCorp Announces Closing of C$23 Million Bought Deal Public Offering

    09
  10. Nov 12, 2025 · 08:30 · PRN

    Profound Medical Announces Strategic Distribution Agreement with Getz Healthcare to Bring TULSA-PRO(TM) to Australia and New Zealand

    Profound Medical Announces Strategic Distribution Agreement with Getz Healthcare to Bring TULSA-PRO(TM) to Australia and New Zealand

    10
  11. Nov 12, 2025 · 07:00 · MBX

    Microbix Partners with SEKISUI Diagnostics to Support COVID/Flu Tests

    Microbix Partners with SEKISUI Diagnostics to Support COVID/Flu Tests

    11
  12. Nov 11, 2025 · 18:03 · PRN

    Profound signs exclusive Saudi Arabia distribution deal

    Profound signs exclusive Saudi Arabia distribution deal

    12
  13. Nov 11, 2025 · 17:15 · CSCI

    COSCIENS Biopharma Inc. Reports Third Quarter 2025 Financial Results and Provides Strategic Initiatives Update

    COSCIENS Biopharma Inc. Reports Third Quarter 2025 Financial Results and Provides Strategic Initiatives Update

    13
  14. Nov 11, 2025 · 17:00 · EXE

    Extendicare Announces 2025 Third Quarter Results

    Extendicare Announces 2025 Third Quarter Results

    14
← Newer Older →